Biohaven’s (BHVN) Outperform Rating Reiterated at Royal Bank of Canada
Royal Bank of Canada restated their outperform rating on shares of Biohaven (NYSE:BHVN – Free Report) in a report published on Tuesday morning,Benzinga reports. The firm currently has a $61.00 price objective on the stock. BHVN has been the subject of a number of other research reports. TD Cowen increased their target price on shares […]
